Literature DB >> 1477961

Expression of the HBNF (heparin-binding neurite-promoting factor) gene in the brain of fetal, neonatal and adult rat: an in situ hybridization study.

B Bloch1, E Normand, I Kovesdi, P Böhlen.   

Abstract

HBNF (heparin-binding neurite-promoting factor) and MK (midkine) are members of a newly recognized family of proteins, the expression of which is developmentally regulated. These proteins are expressed highest during fetal development in many tissues but they seem to be rather restricted to the brain in adult animals. Gene expression for these proteins is inducible by retinoic acid in embryonal carcinoma cell lines. They induce neurite outgrowth in cultured neurons, and they are characterized by high sequence conservation between species. While the function(s) of these proteins are unknown, available evidence suggests possible roles in the development and the maintenance of neural tissues. This in situ hybridization study investigates the temporal and spatial expression pattern of the HBNF gene in the brain of developing rats. The HBNF gene is highly expressed in the neuroepithelium and the ependyma from fetal day 15 on. Although most ependymal structures express the gene strongly, a few restricted areas of the ependyma do not express HBNF (ventral part of the fourth ventricle, subcommissural organ). In the brain parenchyma, HBNF is expressed in the thalamo-hippocampal area from fetal day 15 and in the cerebral cortex from fetal day 16, with high expression occurring in the superficial layers of the cortex. The nature of the cells expressing the gene, while difficult to ascertain, is probably glial for the most part. However, certain neurons (in limited areas of the brain parenchyma) and most pial cells (in the meninges), also express the gene. HBNF gene expression decreases sharply a few days after birth. HBNF mRNA is also detectable at fetal days 15 and 16 in the face fetal mesenchyma. In the adult rat brain, the expression of the HBNF gene appears to be restricted to neurons of the hippocampus and of the olfactory bulb and to the superficial layers of the cortex. The structurally related MK gene, though not extensively studied here, shows an entirely different temporal and spatial expression pattern. MK gene is weakly expressed during ontogeny in most brain areas, and in the adult animal, MK mRNA is present only in the choroid plexus. The intense and widely distributed expression of the HBNF gene in several cell populations in the fetus, the progressive spatial and quantitative restriction of HBNF gene expression with brain differentiation, as well as the properties of the protein suggest important and diverse functions for HBNF in cellular interactions and cell differentiation in the developing brain, that must act temporally and spatially by ways distinct from its MK companion molecule.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1477961     DOI: 10.1016/0165-3806(92)90206-c

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  14 in total

1.  Localization and ontogeny of the orphan receptor OR-1 in the rat brain.

Authors:  T Kainu; J Kononen; E Enmark; J A Gustafsson; M Pelto-Huikko
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

2.  Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-resistant C6 rat glioma cells.

Authors:  Takao Nakagawa; Toshihiko Kubota; Kazunori Ido; Takahiro Sakuma; Ken Matsuda
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

Review 3.  Choroid plexus recovery after transient forebrain ischemia: role of growth factors and other repair mechanisms.

Authors:  C E Johanson; D E Palm; M J Primiano; P N McMillan; P Chan; N W Knuckey; E G Stopa
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

4.  Structure and phylogenetic analysis of an endogenous retrovirus inserted into the human growth factor gene pleiotrophin.

Authors:  A M Schulte; A Wellstein
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity.

Authors:  Peter Landgraf; Petra Wahle; Hans-Christian Pape; Eckart D Gundelfinger; Michael R Kreutz
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

Review 6.  Molecular and pharmacologic targeting of angiogenesis factors--the example of pleiotrophin.

Authors:  F Czubayko; A M Schulte; S C Missner; S S Hsieh; K J Colley; A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

7.  Down syndrome-critical region contains a gene homologous to Drosophila sim expressed during rat and human central nervous system development.

Authors:  N Dahmane; G Charron; C Lopes; M L Yaspo; C Maunoury; L Decorte; P M Sinet; B Bloch; J M Delabar
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

Review 8.  Pleiotrophin as a central nervous system neuromodulator, evidences from the hippocampus.

Authors:  Celia González-Castillo; Daniel Ortuño-Sahagún; Carolina Guzmán-Brambila; Mercè Pallàs; Argelia Esperanza Rojas-Mayorquín
Journal:  Front Cell Neurosci       Date:  2015-01-08       Impact factor: 5.505

9.  The effects of pleiotrophin in proliferative diabetic retinopathy.

Authors:  Xuemei Zhu; Yujing Bai; Wenzhen Yu; Chungting Pan; Enzhong Jin; Dan Song; Qiong Xu; Yuou Yao; Lvzhen Huang; Yong Tao; Xiaoxin Li; Mingwei Zhao
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

10.  K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney.

Authors:  K Watanabe; H Yamada; Y Yamaguchi
Journal:  J Cell Biol       Date:  1995-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.